Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)

Frederick S. Kaplan, Robert J. Pignolo, Mona M. Al Mukaddam, Eileen M. Shore

Research output: Contribution to journalEditorialpeer-review

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)291-294
Number of pages4
JournalExpert Opinion on Orphan Drugs
Issue number4
StatePublished - Apr 3 2017


  • ACVR1
  • Activin A
  • bone morphogenetic protein receptors
  • fibrodysplasia ossificans progressiva
  • heterotopic endochondral ossification
  • hypoxia

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy
  • Pharmacology (medical)

Cite this